Dan Loeb's Third Point acquired an 8.9 million stake in Kenvue in Q1 2025, making it a top five holding. Kenvue updated its FY25 outlook to reflect higher tariff costs and currency impacts ...

Kenvue has launched a new TYLENOL® product, *Proactive Support*, which aims to improve joint health and promote an active lifestyle for older adults. The introduction of this innovative product ...

SUMMIT, N.J., June 02, 2025--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced it has made the prestigious ...

On Wednesday, Jefferies analysts reiterated their Buy rating for Kenvue Inc (NYSE: KVUE), maintaining a price target of $27.00. According to InvestingPro data, analyst targets range from $22 to $ ...

Shares of Kenvue (NYSE:KVUE) are under pressure Tuesday and experiencing their worst day since splitting from Johnson & Johnson (JNJ) and going public in 2023 after CEO Thibaut Mongon warned of ...

Investing.com -- Jefferies believes investors should take advantage of recent weakness in Kenvue (NYSE:KVUE) stock, reiterating a Buy rating and calling the company a “self-help transformation story” ...

On Wednesday, Jefferies analysts reiterated their Buy rating for Kenvue Inc (NYSE: KVUE), maintaining a price target of $27.00. According to InvestingPro data, analyst targets range from $22 to $29, ...

Kenvue has a better P/E ratio of 42.38 than the aggregate P/E ratio of 36.56 of the Personal Products industry. Ideally, one might believe that Kenvue Inc. might perform better in the future than ...

Wide-moat Kenvue's shares declined roughly 6% after the firm hinted at persistent market challenges at an investor conference. Management pointed to two dynamics—inventory destocking and weak ...